InMed Pharmaceuticals Inc（INM）價格預測INMInMed Pharmaceuticals Inc

Alphio's INM stock price prediction model matches the current InMed Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.33 (+1.08%). The 1-week path is $1.31 (-1.10%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

InMed Pharmaceuticals is not a good buy right now due to its low RSI of 31.092, indicating oversold conditions, and a significant 1-year change of -36.11%. While the recent merger news may provide some potential upside, the current financial performance shows a troubling trend with a net income loss of -2,966,336 USD in Q3 2026 and a gross margin drop to 15.97% in Q2 2026, which raises concerns about its profitability and sustainability.

InMed Pharmaceuticals Inc (INM) last closed at $1.32, losing -2.22%. These facts feed the 1-day and 1-week INM price prediction above.